| MeSH term | MeSH ID | Detail |
|---|---|---|
| Vaginosis, Bacterial | D016585 | 10 associated lipids |
| Influenza, Human | D007251 | 11 associated lipids |
| Candidiasis, Oral | D002180 | 11 associated lipids |
| Pregnancy Complications, Infectious | D011251 | 11 associated lipids |
| HIV Seropositivity | D006679 | 15 associated lipids |
| Dermatomycoses | D003881 | 17 associated lipids |
| Mycoses | D009181 | 18 associated lipids |
| Leishmaniasis | D007896 | 19 associated lipids |
| Anemia, Sickle Cell | D000755 | 34 associated lipids |
| Burns | D002056 | 34 associated lipids |
Nystatin A3
Nystatin A3 is a lipid of Polyketides (PK) class. Nystatin a3 is associated with abnormalities such as Mycoses, Candidiasis of the genitals and Gigantism. The involved functions are known as Drug Interactions, Process, Synthesis, Fermentation and Anabolism. Nystatin a3 often locates in Cell membrane, Membrane, Protoplasm, Entire oral cavity and integral to membrane. The associated genes with Nystatin A3 are Gene Clusters. The related lipids are Sterols, 1,2-oleoylphosphatidylcholine, Membrane Lipids, DOPE and N-caproylsphingosine.
Cross Reference
Introduction
To understand associated biological information of Nystatin A3, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Nystatin A3?
Nystatin A3 is suspected in Mycoses, Candidiasis of the genitals, Gigantism and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Nystatin A3
PubChem Associated disorders and diseases
What pathways are associated with Nystatin A3
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Nystatin A3?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Nystatin A3?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Nystatin A3?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Nystatin A3?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Nystatin A3?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Nystatin A3
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Manzoni P et al. | Prevention of nosocomial infections in neonatal intensive care units. | 2013 | Am J Perinatol | pmid:23292914 |
| Ouyang W et al. | Absence of death receptor translocation into lipid rafts in acquired TRAIL-resistant NSCLC cells. | 2013 | Int. J. Oncol. | pmid:23258590 |
| Daneman N et al. | Effect of selective decontamination on antimicrobial resistance in intensive care units: a systematic review and meta-analysis. | 2013 | Lancet Infect Dis | pmid:23352693 |
| Hu R et al. | Prospective trial finds nystatin mouthwash effective prophylaxis for pulmonary invasive fungal infections that originate in the throat of patients with hematologic malignancies. | 2013 | Neoplasma | pmid:23374002 |
| Tevyashova AN et al. | Structure-antifungal activity relationships of polyene antibiotics of the amphotericin B group. | 2013 | Antimicrob. Agents Chemother. | pmid:23716057 |
| Torres-Alvarez B et al. | Cutaneous congenital candidiasis in a full-term newborn from an asymptomatic mother. | 2013 | Dermatol. Online J. | pmid:24010513 |
| Tugizov SM et al. | Epstein-Barr virus transcytosis through polarized oral epithelial cells. | 2013 | J. Virol. | pmid:23698302 |
| Stoopler ET | Management of oral chronic graft-versus-host disease. | 2013 | J Can Dent Assoc | pmid:23763728 |
| Ceccarelli G et al. | Topical nystatin prophylaxis: a likely viable measure for reducing impact of candidemia in neurosurgical patients with early tracheostomy intubation. | 2013 | Crit Care | pmid:23414732 |
| Hothersall JD et al. | Prolonged inhibition of 5-HT₃ receptors by palonosetron results from surface receptor inhibition rather than inducing receptor internalization. | 2013 | Br. J. Pharmacol. | pmid:23581504 |
| Bosanquet DC et al. | Topical steroids for chronic wounds displaying abnormal inflammation. | 2013 | Ann R Coll Surg Engl | pmid:23676816 |
| Semis R et al. | Mechanism of activity and toxicity of Nystatin-Intralipid. | 2013 | Med. Mycol. | pmid:23088298 |
| Giuliano S et al. | Candidemia in Neurosurgical Intensive Care Unit: preliminary analysis of the effect of topical Nystatin prophylaxis and adequate source control on patients with early tracheostomy intubation. | 2013 Jan-Feb | Ann Ig | pmid:23435780 |
| Sklenár Z et al. | Compounded preparations with nystatin for oral and oromucosal administration. | 2013 Jul-Aug | Acta Pol Pharm | pmid:23923400 |
| Lewis M | The role of antifungal and antiviral agents in primary dental care. | 2014 | Prim Dent J | pmid:25668378 |
| Ellepola AN et al. | The postantifungal effect of nystatin and its impact on adhesion attributes of oral Candida dubliniensis isolates. | 2014 | Mycoses | pmid:23773155 |
| Li D et al. | Efficacy and safety of probiotics in the treatment of Candida-associated stomatitis. | 2014 | Mycoses | pmid:23952962 |
| Ruhil S et al. | In vitro evaluation of combination of polyenes with EDTA against Aspergillus spp. by different methods (FICI and CI Model). | 2014 | J. Appl. Microbiol. | pmid:24931000 |
| Curvelo JA et al. | Effect of the secretory leucocyte proteinase inhibitor (SLPI) on Candida albicans biological processes: a therapeutic alternative? | 2014 | Arch. Oral Biol. | pmid:24907522 |
| Hussein-Al-Ali SH et al. | Antimicrobial and controlled release studies of a novel nystatin conjugated iron oxide nanocomposite. | 2014 | Biomed Res Int | pmid:24900976 |